• Rabies - You don't know what you know

  • 2024/12/03
  • 再生時間: 19 分
  • ポッドキャスト

Rabies - You don't know what you know

  • サマリー

  • Human rabies cases are fortunately rare in the US. Access to pre- and post-exposure prophylaxis, and domestic animal vaccination programs, drive this public health success. This comes at a financial and human resources cost. Dr. Kyle Weant, clinical assistant professor and an emergency medical clinical pharmacy specialist at the University of South Carolina College of Pharmacy and Dr. Philippe Mentler, senior consulting director, join host Gretchen Brummel to discuss the use of rabies immune globulin and rabies vaccine in patients who have been exposed and provide treatment pearls for frontline pharmacy practioners.

    Guest speakers:

    Kyle Weant, PharmD, BCPS, BCCCP, FCCP

    Clinical Assistant Professor and an Emergency Medical Clinical Pharmacy Specialist

    University of South Carolina College of Pharmacy

    Philippe Mentler, PharmD, BCPS

    Senior Consulting Director

    Vizient

    Host:

    Gretchen Brummel, PharmD, BCPS

    Show Notes:

    [00:54-01:17] Kyle’s background information

    [01:18-03:31] Rabies as a disease

    [03:32-05:13] Public Awareness

    [05:14-07:06] Options right now for post-exposure prophylaxis

    [07:07-10:01] Thoughts on dose rounding

    [10:02-10:13] Is rabies immunoglobulin considered an essential medication that everyone should stock in their hospital pharmacy

    [10:14-11:30] Who should be administering these drugs? And who's ensuring follow up of these patients?

    [11:31-14:31] Potential pitfalls in patient management

    [14:32-18:12] What should our frontline pharmacy staff know about post-exposure prophylaxis

    Subscribe Today!

    Apple Podcasts

    Amazon Podcasts

    Spotify

    Android

    RSS Feed

    続きを読む 一部表示

あらすじ・解説

Human rabies cases are fortunately rare in the US. Access to pre- and post-exposure prophylaxis, and domestic animal vaccination programs, drive this public health success. This comes at a financial and human resources cost. Dr. Kyle Weant, clinical assistant professor and an emergency medical clinical pharmacy specialist at the University of South Carolina College of Pharmacy and Dr. Philippe Mentler, senior consulting director, join host Gretchen Brummel to discuss the use of rabies immune globulin and rabies vaccine in patients who have been exposed and provide treatment pearls for frontline pharmacy practioners.

Guest speakers:

Kyle Weant, PharmD, BCPS, BCCCP, FCCP

Clinical Assistant Professor and an Emergency Medical Clinical Pharmacy Specialist

University of South Carolina College of Pharmacy

Philippe Mentler, PharmD, BCPS

Senior Consulting Director

Vizient

Host:

Gretchen Brummel, PharmD, BCPS

Show Notes:

[00:54-01:17] Kyle’s background information

[01:18-03:31] Rabies as a disease

[03:32-05:13] Public Awareness

[05:14-07:06] Options right now for post-exposure prophylaxis

[07:07-10:01] Thoughts on dose rounding

[10:02-10:13] Is rabies immunoglobulin considered an essential medication that everyone should stock in their hospital pharmacy

[10:14-11:30] Who should be administering these drugs? And who's ensuring follow up of these patients?

[11:31-14:31] Potential pitfalls in patient management

[14:32-18:12] What should our frontline pharmacy staff know about post-exposure prophylaxis

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed

Rabies - You don't know what you knowに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。